Loading the catalog…
Loading the catalog…
THE AI OPPORTUNITY INDEX
Find your next AI tool. Explore free access, trials, and credits — all in one place.
Hugging Face
Score: 41.53Confidence: 53%
OpenAI
OpenAI for Singapore launches a multi-year AI partnership to expand deployment, build local talent, and support businesses and public services with AI.
Score: 41.52Confidence: 59%
View offerOpenAI
OpenAI advances AI content provenance with Content Credentials, SynthID, and a verification tool to help people identify and trust AI-generated media.
Score: 41.51Confidence: 59%
View offerGoogle DeepMind
Biologists use Co-Scientist to find novel factors that successfully rejuvenate human cells.
Score: 41.5Confidence: 59%
View offerTogether.ai
Real-world inference benchmarks for coding agents: 31% more TPS than TensorRT-LLM, 2× better TTFT at saturation, and 76% lower cost than Claude Opus 4.6.
Score: 41.5Confidence: 59%
View offerOpenAI
OpenAI and Dell partner to bring Codex to hybrid and on-premise environments, helping enterprises deploy AI coding agents securely across data and workflows.
Score: 41.49Confidence: 59%
View offerGoogle DeepMind
A collection of science tools and experiments to expand the scale and precision of scientific exploration.
Score: 41.47Confidence: 59%
View offerGoogle DeepMind
We're expanding our tools to help you understand how content was created and edited across the web.
Score: 41.47Confidence: 59%
View offerGoogle DeepMind
Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
Score: 41.44Confidence: 59%
View offerGoogle DeepMind
Google DeepMind and Singapore partner to apply frontier AI to address complex challenges across health, education, and sustainability and more.
Score: 41.44Confidence: 59%
View offerGoogle DeepMind
Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.
Score: 41.44Confidence: 59%
View offerGoogle DeepMind
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Score: 41.44Confidence: 59%
View offer